Literature DB >> 7567346

Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric Utstein style. A statement for healthcare professionals from a task force of the American Academy of Pediatrics, the American Heart Association, and the European Resuscitation Council.

A Zaritsky1, V Nadkarni, M F Hazinski, G Foltin, L Quan, J Wright, D Fiser, D Zideman, P O'Malley, L Chameides.   

Abstract

This consensus document is an attempt to provide an organized method of reporting pediatric ALS data in out-of-hospital, emergency department, and in-hospital settings. For this methodology to gain wide acceptance, the task force encourages development of a common data set for both adult and pediatric ALS interventions. In addition, every effort should be made to ensure that consistent definitions are used in all age groups. As health care changes, we will all be challenged to document the effectiveness of what we currently do and show how new interventions or methods of treatment improve outcome and/or reduce cost. Only through collaborative research will we obtain the necessary data. For these reasons, and to improve the quality of care and patient outcomes, it is the hope of the task force that clinical researchers will follow the recommendations in this document. It is recognized that further refinements of this statement will be needed; these recommendations will improve only when researchers, clinicians, and EMS personnel use them, work with them, and modify them. Suggestions, emendations, and other comments aimed at improving the reporting of pediatric resuscitation should be sent to Arno Zaritsky, MD, Eastern Virginia Medical School, Children's Hospital of The King's Daughter, Division of Critical Care Medicine, 601 Children's Lane, Norfolk, VA 23507.

Entities:  

Mesh:

Year:  1995        PMID: 7567346

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Outcome prediction by motor and pupillary responses in children treated with therapeutic hypothermia after cardiac arrest.

Authors:  Nicholas S Abend; Alexis A Topjian; Sudha Kilaru Kessler; Ana M Gutierrez-Colina; Robert A Berg; Vinay Nadkarni; Dennis J Dlugos; Robert R Clancy; Rebecca N Ichord
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

2.  Outcome of in-hospital pediatric cardiopulmonary arrest from a single center in Pakistan.

Authors:  Anwarul Haque; Arjumand Rizvi; Surraiya Bano
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

3.  Reduction of paediatric in-patient cardiac arrest and death with a medical emergency team: preliminary results.

Authors:  J Tibballs; S Kinney; T Duke; E Oakley; M Hennessy
Journal:  Arch Dis Child       Date:  2005-11       Impact factor: 3.791

4.  Women of child-bearing age have better inhospital cardiac arrest survival outcomes than do equal-aged men.

Authors:  Alexis A Topjian; A Russell Localio; Robert A Berg; Evaline A Alessandrini; Peter A Meaney; Paul E Pepe; G Luke Larkin; Mary Ann Peberdy; Lance B Becker; Vinay M Nadkarni
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

5.  Child with absent vital signs.

Authors:  N Kissoon
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

6.  A tertiary care center's experience with therapeutic hypothermia after pediatric cardiac arrest.

Authors:  Ericka L Fink; Robert S B Clark; Patrick M Kochanek; Michael J Bell; R Scott Watson
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

7.  NEUROlogical Prognosis After Cardiac Arrest in Kids (NEUROPACK) study: protocol for a prospective multicentre clinical prediction model derivation and validation study in children after cardiac arrest.

Authors:  Barnaby Robert Scholefield; James Martin; Kate Penny-Thomas; Sarah Evans; Mirjam Kool; Roger Parslow; Richard Feltbower; Elizabeth S Draper; Victoria Hiley; Alice J Sitch; Hari Krishnan Kanthimathinathan; Kevin P Morris; Fang Smith
Journal:  BMJ Open       Date:  2020-09-25       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.